Evidence map›Paper›PMID 39171088›Full record

ArticleBiochemia medica2024

Serum concentration of ferroportin in women of reproductive age.

Ana Ćuk, Lada Rumora, Ivanka Mikulić, Nikolina Penava, Ivona Cvetković, Ante Pušić, Vinka Mikulić, Kristina Ljubić, Vajdana Tomić

Abstract read
In one paragraph

Article in Biochemia medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana ĆukDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Lada RumoraDepartment of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Ivanka MikulićDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Nikolina PenavaDepartment of Obstetrics and Gynecology, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Ivona CvetkovićDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Ante PušićDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Vinka MikulićDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Kristina LjubićDepartment of Laboratory Diagnostics, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.
Vajdana TomićDepartment of Obstetrics and Gynecology, Clinical Hospital Centre Mostar, Mostar, Bosnia and Herzegovina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ferroportin (Fpn) is the only known iron exporter and plays an essential role in iron homeostasis. Serum concentrations of Fpn in health and/or diseased states are still mostly unknown. Therefore, the aim of this study was to determine the concentration of Fpn in the serum of women of reproductive age (WRA) for the first time, and to establish whether there is a difference in the concentration of Fpn according to ferritin status. Materials and methods: This research included 100 WRA (18-45 years, C-reactive protein (CRP) < 5 mg/L, hemoglobin > 120 g/L). Serum Fpn was measured using Enzyme Linked Immunosorbent Assay (ELISA) method on the analyzer EZ Read 800 Plus (Biochrom, Cambridge, UK). Reference interval was calculated using the robust method. Results: The median concentration of Fpn in the whole study group was 9.74 (5.84-15.69) µg/L. The subgroup with ferritin concentration > 15 µg/L had a median Fpn concentration 15.21 (10.34-21.93) µg/L, which significantly differed from Fpn concentration in the subgroup with ferritin concentration ≤ 15 µg/L (5.93 (4.84-8.36) µg/L, P < 0.001). The reference limits for the Fpn were 2.26-29.81 µg/L with 90% confidence intervals (CI) of 1.78 to 2.83 and 25.37 to 34.33, respectively. Conclusions: The proposed reference interval could help in the future research on iron homeostasis both in physiological conditions and in various disorders, because this is the first study that measured Fpn concentration in a certain gender and age group of a healthy population.

Indexed as

Cation Transport ProteinsFerritinsAdolescentAdultEnzyme-Linked Immunosorbent AssayFemaleFerroportinHumansIronMiddle AgedReference ValuesYoung AdultCation Transport ProteinsFerritinsFerroportinIronferritinferroportinironreference interval

Identifiers

PMID39171088
PMCPMC11334195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.